1. Mathai V, Idikula J, Fenn AS, Nair A. Do long-standing nodular goitres result in malignancies? Aust N Z J Surg. 1994. 64:180–182.
Article
2. Hishinuma A, Fukata S, Kakudo K, Murata Y, Ieiri T. High incidence of thyroid cancer in long-standing goiters with thyroglobulin mutations. Thyroid. 2005. 15:1079–1084.
Article
3. Tramontano D, Moses AC, Veneziani BM, Ingbar SH. Adenosine 3', 5'-monophosphate mediates both the mitogenic effect of thyrotropin and its ability to amplify the response to insulin-like growth factor I in FRTL5 cells. Endocrinology. 1988. 122:127–132.
4. Takahashi S, Conti M, Van Wyk JJ. Thyrotropin potentiation of insulin-like growth factor-I dependent deoxribonucleic acid synthesis in FRTL-5 cells: mediation by an autocrine amplification factor(s). Endocrinology. 1990. 126:736–745.
Article
5. Yamamoto K, Hirai A, Ban T, Saito J, Tahara K, Terano T, Tamura Y, Saito Y, Kitagawa M. Thyrotropin induces G1 cyclin expression and accelerates G1 phase after insulin-like growth factor I stimulation in FRTL-5 cells. Endocrinology. 1996. 137:2036–2042.
Article
6. Kimura T, Van Keymeulen A, Golstein J, Fusco A, Dumont JE, Roger PP. Regulation of thyroid cell proliferation by TSH and other factors?: a critical evaluation of in vitro models. Endocr Rev. 2001. 22:631–656.
Article
7. Park YJ, Kim TY, Lee SH, Kim H, Kim SW, Shong M, Yoon YK, Cho BY, Park DJ. p66Shc expression in proliferating thyroid cells is regulated by thyrotropin receptor signaling. Endocrinology. 2005. 146:2473–2480.
Article
8. Yamazaki K, Yamada E, Kanaji Y, Yanagisawa T, Kato Y, Takano K, Obara T, Sato K. Genes regulated by thyrotropin and iodide in cultured human thyroid follicles: analysis by cDNA microarray. Thyroid. 2003. 13:149–158.
Article
9. Yang YH, Dudoit S, Luu P, Lin DM, Peng V, Ngai J, Speed TP. Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res. 2002. 30:e15.
Article
10. Deleu S, Savonet V, Behrends J, Dumont JE, Maenhaut C. Study of gene expression in thyrotropin-stimulated thyroid cells by cDNA expression array: ID3 transcription modulating factor as an early response protein and tumor marker in thyroid carcinoma. Exp Cell Res. 2002. 279:62–70.
11. Bruno R, Ferretti E, Tosi E, Arturi F, Giannasio P, Mattei T, Scipioni A, Presta I, Morisi R, Gulino A, Filetti S, Russo D. Modulation of thyroid-specific gene expression in normal and nodular human thyroid tissues from adults: an in vivo effect of thyrotropin. J Clin Endocrinol Metab. 2005. 90:5692–5697.
Article
12. Ebisawa T, Tada K, Kitajima I, Tojo K, Sampath TK, Kawabata M, Miyazono K, Imamura T. Characterization of bone morphogenetic protein-6 signaling pathways in osteoblast differentiation. J Cell Sci. 1999. 112:3519–3527.
Article
13. Ericson J, Norlin S, Jessell TM, Edlund T. Integrated FGF and BMP signaling controls the progression of progenitor cell differentiation and the emergence of pattern in the embryonic anterior pituitary. Development. 1998. 125:1005–1015.
Article
14. Kraunz KS, Nelson HH, Liu M, Wiencke JK, Kelsey KT. Interaction between the bone morphogenetic proteins and Ras/MAP-kinase signalling pathways in lung cancer. Br J Cancer. 2005. 93:949–952.
Article
15. Suzuki J, Otsuka F, Takeda M, Inagaki K, Miyoshi T, Mimura Y, Ogura T, Doihara H, Makino H. Functional roles of the bone morphogenetic protein system in thyrotropin signaling in porcine thyroid cells. Biochem Biophys Res Commun. 2005. 327:1124–1130.
Article
16. Hansen LH, Abrahamsen N, Nishimura E. Glucagon receptor mRNA distribution in rat tissues. Peptides. 1995. 16:1163–1166.
Article
17. Morales A, Lachuer J, Duchamp C, Vera N, Georges B, Cohen-Adad F, Moulin C, Barre H. Tissue-specific modulation of rat glucagon receptor mRNA by thyroid status. Mol Cell Endocrinol. 1998. 144:71–81.
Article
18. Navarro I, Leibush B, Moon TW, Plisetskaya EM, Banos N, Mendez E, Planas JV, Gutierrez J. Insulin, insulin-like growth factor-I (IGF-I) and glucagon: the evolution of their receptors. Comp Biochem Physiol B Biochem Mol Biol. 1999. 122:137–153.
Article
19. Ginda WJ. Evidence for a functional role of cholecystokinin receptors in the rat thyroid gland. Folia Histochem Cytobiol. 2001. 39:331–334.
20. Ahren B. Regulatory peptides in the thyroid gland--a review on their localization and function. Acta Endocrinol (Copenh). 1991. 124:225–232.
21. Timler D, Tazbir J, Matejkowska M, Gosek A, Czyz W, Brzezinski J. Expression of proteins: D1 cyclin and Ki-67 in papillary thyroid carcinomas. Folia Histochem Cytobiol. 2001. 39:Suppl 2. 201–202.
22. Wang S, Lloyd RV, Hutzler MJ, Safran MS, Patwardhan NA, Khan A. The role of cell cycle regulatory protein, cyclin D1, in the progression of thyroid cancer. Mod Pathol. 2000. 13:882–887.
Article
23. Lubitz CC, Gallagher LA, Finley DJ, Zhu B, Fahey TJ 3rd. Molecular analysis of minimally invasive folllicular carcinomas by gene profiling. Surgery. 2005. 138:1042–1048.
24. Yoo HY, Oh SK, Yi KH, Cho BY, Koh CS. Effect of growth factors on the expression of proto-oncogenes c-fos and c-myc in FRTL-5 cell line. J Korean Med Sci. 1995. 10:155–163.
Article
25. Takada K, Amino N, Tada H, Miyai K. Relationship between proliferation and cell cycle-dependent Ca2+ influx induced by a combination of thyrotropin and insulin-like growth factor-1 in rat thyroid cells. J Clin Invest. 1990. 86:1548–1555.
26. Vandeput F, Zabeau M, Maenhaut C. Identification of differentially expressed genes in thyrotropin stimulated dog thyroid cells by the cDNA-AFLP technique. Mol Cell Endocrinol. 2005. 243:58–65.
Article